Joint Pain Injection Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Drug (Hyaluronic Acid, Corticosteroid, and Others), Joint Type (Knee, Foot and Ankle, Shoulder and Elbow, Hip, and Others), and Distribution Channel (Retail Pharmacies, Hospitals Pharmacies, and Others)
Publication Month: Apr 2021 | Report Code: TIPRE00003536 | No. of Pages: 162 | Category: Pharmaceuticals | Status: Published
The joint pain injection market is expected to reach US$ 6,996.88 million by 2028 from US$ 3,667.45 million in 2020; it is estimated to grow at a CAGR of 8.5% during 2021–2028.
Joint pain injections provide faster relief from severe pain and reduce inflammation of joints. Several types of injections available in the market include corticosteroids injections, hyaluronic acid (HA) injections, platelet-rich plasma (PRP) injections, and placental tissue matrix (PTM) injections. The growth of the joint pain injection market is attributed to the factors such as high prevalence of musculoskeletal disorders and increasing number of sports injuries. However, high costs of joint repair therapies hinder the market growth
Lucrative Regions for Joint Pain Injection Market
Get more information on this report :
Market Insights
High Prevalence of Musculoskeletal Disorders
Musculoskeletal disorders are medical conditions affecting muscles, bones, and joints of neck, shoulders, wrists, back, hips, legs, knees, and feet. These diseases include tendinitis, carpal tunnel syndrome, osteoarthritis, rheumatoid arthritis (RA), fibromyalgia, and bone fractures. As per the World Health Organization (WHO) factsheet updated in 2018, musculoskeletal conditions are the second-largest contributor to disability worldwide. According to the same, the prevalence and impact of musculoskeletal disorders is expected to rise with the increase in aging population and rise in the prevalence of risk factors of noncommunicable diseases (NCDs) worldwide. As per 2016 American Academy of Orthopedic Surgeons’ annual meeting data, ~1 in 2 adults is suffering from a musculoskeletal disorder in the US. Further, according to the Centers for Disease Control and Prevention (CDC), arthritis causes severe pain that affects millions of people in the US every year. Around one in four arthritis patients, i.e., ~15 million of total ~54 million patients, experiences severe arthritis-related joint pain.
Further, osteoarthritis (OA) is one of the most common joint disorders in the US, caused by the breakdown of joint cartilage between bones. It is also known as degenerative joint disease or “wear and tear” arthritis. As per the Centers for Disease Control and Prevention (CDC), more than 32.5 million adults in the US suffer from osteoarthritis. Similarly, as per the National Health Service (NHS), more than 10 million people in the UK have arthritis or other similar conditions that affect joints. As per the Bupa Health Insurance, osteoarthritis is the most common form of arthritis prevalent in the UK, it affects around the one-third of people aged 45 or more in the country, i.e., ~8.75 million people. Therefore, such high prevalence of musculoskeletal disorders in different countries is increasing the number of treatment procedures being carried out for the same, thereby driving the joint pain injection market growth.
Drugs-Based Insights
The joint pain injection market, by drug, is segmented into hyaluronic acid, corticosteroid, and others. The corticosteroid segment held the largest share of the market in 2020, and it is further anticipated to register the highest CAGR during the forecast period.
Joint pain injection Market, by Drug– 2020 and 2028
Get more information on this report :
Joint Type-based Insights
Based on joint type, the joint pain injection market is segmented into knee, foot and ankle, shoulder and elbow, hips, and other applications. The knee segment held the largest market share in 2020 and is anticipated to register the highest CAGR in the market during the forecast period.
Distribution Channel-based Insights
Based on distribution channel, the joint pain injection market is segmented into retail pharmacies, hospitals pharmacies, and others. The wound care segment held the largest market share in 2020, and the bone grafts segment is estimated to register the highest CAGR in the market during the forecast period.
Strategic Insights
Product launches and approvals are the commonly adopted strategies by companies to expand their global footprints and product portfolios. Moreover, the joint pain injection market players focus on the collaboration strategy to enlarge their clientele, which, in turn, permits them to maintain their brand name globally.
Joint Pain Injection Market – by Drug
- Hyaluronic Acid
- Corticosteroid
- Others
Joint Pain Injection Market – by Joint Type
- Knee
- Foot and Ankle
- Shoulder and Elbow
- Hip
- Others
Joint Pain Injection Market – by Distribution Channel
- Retail Pharmacies
- Hospitals Pharmacies
- Others
Joint Pain Injection Market – by Geography
North America
- US
- Canada
- Mexico
Europe
- France
- Germany
- Italy
- UK
- Spain
- Rest of Europe
Asia Pacific (APAC)
- China
- India
- South Korea
- Japan
- Australia
- Rest of Asia Pacific
Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Rest of Middle East and Africa
South and Central America (SCAM)
- Brazil
- Argentina
- Rest of South and Central America
Company Profiles
- Chugai Pharmaceutical Co., Ltd.
- Bioventus Inc.
- Fidia Pharma USA Inc.
- Flexion Therapeutics, Inc.
- SEIKAGAKU CORPORATION
- Ferring B.V.
- Sanofi
- Anika Therapeutics, Inc.
- Teva Pharmaceutical
- OrthogenRx, Inc.
Frequently Asked Questions
The List of Companies - Joint Pain Injection Market
- Chugai Pharmaceutical Co., Ltd.
- Bioventus Inc.
- Fidia Pharma USA Inc.
- Flexion Therapeutics, Inc.
- SEIKAGAKU CORPORATION
- Ferring B.V.
- Sanofi
- Anika Therapeutics, Inc.
- Teva Pharmaceutical
- OrthogenRx, Inc.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the joint pain injection market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the global joint pain injection market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Get the Latest COVID-19 Analysis on this market
Have a Question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
-
$3000
-
$4550
-
$6550
-
$8550
-
Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.
Inquire for Discount